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Summary 
Interleukin-2 (IL-2)-deficient (IL-2 -/-) mice develop anemia and colonic inflammatory bowel 
disease.  To elucidate the mechanism of this disease, we have bred IL-2 -/- mice to two strains 
of immunodeficient mice, RAG-2-deficient (RAG-2 -/-, lacking B  and T  cells)  andJH-defi- 
cient mice (JH  -/-, lacking B  cells).  IL-2 -/-,  RAG-2 -/- double-mutant mice are disease free, 
while IL-2-/-,JH -/- double-mutant mice succumb to bowel disease at the same rate as ILo2 -/- 
littermates.  IL-2 -/-, JH -/- mice do not, however, succumb to anemia. Thus, spontaneous in- 
testinal inflammation in IL-2 -/- mice requires mature T  cells,  not B  cells,  while anemia is de- 
pendent on B  cells. 
T 
ransgenic mice bearing targeted deletions for IL-2, IL- 
10, MHC  class II,  or  TCR-fl genes develop intestinal 
inflammation  (1-3).  These  findings  have  opened  multiple 
avenues of investigation into the regulation of immune re- 
sponses  in  the  intestinal  epithelium.  The  pathophysiolo- 
gical  mechanisms  of bowel  inflammation  in  these  diverse 
transgenic animals is unclear, although (a) a primary pertur- 
bation of the mucosal immune response seems to occur in 
all  cases;  and  (b)  the presence  of luminal  bacteria  or their 
products  influences  the  manifestation  of disease.  Distur- 
bances in the balance between immunoregulatory lympho- 
cyte subsets and/or cytokine imbalances have been postu- 
lated to be pathogenetic in these mice (4,  5). 
The presence  or expansion  of particular lymphoid sub- 
sets  provides some clues as to the effector cells  responsible 
for these  diseases.  For example,  TCR[3 -/-  and  TCRcx -l- 
mice  develop  bowel  inflammation  without  cx/[~T  cells, 
while  RAG-1 -/-  animals,  which lack both B  and T  cells, 
do not, suggesting that the loss of an imrnunoregulatory T 
cell subset combined with an intact B  cell population may 
lead  to  B  cell-mediated  autoimmune  disease  (3,  5,  6). 
Bowel inflammation in MHC class II  -/- mice, which selec- 
tively lack  class  II-restricted  CD4 +  T  cells,  could also  be 
caused by such a mechanism (3). 
IL-2  -/-  mice initially contain normal numbers of B  and 
T  lymphocytes, and the lamina propria of inflamed colons 
in older mice contain  elevated levels of CD4 + and CD8 + 
T  cells,  as well as B220 + B cells,  suggesting that both T  and 
B  cells are spontaneously activated in the  colonic immune 
response  (1,  6).  In addition,  anticolon antibodies  are regu- 
larly detected in the serum, and these antibodies have been 
postulated  to be involved in causing bowel  disease  (1,  5). 
Together,  these  observations  suggest  that  T  cells,  B  cells, 
and  their  autoantibody products  may all  be  important  for 
the development of bowel disease in IL-2  -/-  animals. 
To determine the relative roles ofT and B cells in IL-2  -/- 
transgenic  mice  and  to  specifically  evaluate  their  role  in 
mediating  bowel  disease,  we  have  bred  IL-2 -/-  mice  to 
two  strains  of immuodeficient  mice: JH  -/-  mice,  which 
bear a targeted deletion of Ig heavy chain J  gene segments, 
and  possess  no  mature  B  cells  (7);  and  RAG-2 -/-  mice, 
which bear a targeted deletion of the RAG-2 gene, cannot 
rearrange B or T  cell antigen receptor genes, and thus pos- 
sess no mature T  or B  cells  (8).  We report here the histo- 
logical and clinical findings in these various single and dou- 
ble mutant transgenic mice. 
Materials  and Methods 
Breeding and Housing of lL-2 -/-, JH  -/-,  and RAG-2 -/-  Mice. 
All mice were housed and bred within one track in the specific 
pathogen-free barrier facility of the Animal Research Facility at 
Children's Hospital.  Animals were monitored weekly for the de- 
velopment of loose bowel movements, wasting,  or anemia.  Clin- 
ically ill animals were monitored twice per week and killed when 
severely ill. 
Colonic Histopathology.  Colons fi-om freshly killed animals were 
flushed  with PBS to remove stool contents. Cross-sections  were 
frozen directly in OCT compound (Miles Laboratories,  Inc., Na- 
perville,  IL)  using  a  cryostat  (Bright  Instruments,  Huntingdon, 
UK). Frozen sections  were cut on the cryostat  and stained  with 
hematoxylin and eosin. 
Assessment of  Anemia.  Cardiac puncture was performed immedi- 
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ized microhematocrit capillary tubes (Fisher Scientific, Pittsburgh, 
PA), Capillary tubes were then centrifuged for 5 min, and hema- 
tocrits were directly measured in the tubes. 
Analysis of Lamina Propria Lymphocytes (LPLs).  LPLs  were har- 
vested from individual colons of diseased mice, or from two to 
three nondiseased  controls using an adapted  version of a previ- 
ously  described  protocol  (9). Briefly,  colons were  rinsed with 
HBSS  (GIBCO BRL, Gaithersburg,  MD), incubated with serial 
washes of HBSS with 1 mM EDTA, washed,  equilibrated with 
RPMI  with  10%  FCS  and J~-mercaptoethanol,  and incubated 
with RPMI with collagenase and DNAse (0.1 mg/ml; Sigma Ira- 
munochemicals, St. Louis, MO) in a shaking incubator at 37~ 
Liberated  LPLs were  purified  via  Percoll  gradient  (Sigma), 
washed, resuspended  in PBS with 5% FCS, and stained with PE- 
or FITC-conjugated mAbs specific for CD3, CD4, CD8, CD69, 
B220, IgM, and M290 antigens (Pharmingen, San Diego, CA; 10) 
for 20 rain at 4~  After washing, lymphocytes were analyzed on 
a FACStar Plus  |  (Becton Dickinson & Co., Mountain View, CA). 
Results 
Bowel Inflammation in IL-2 -/-,  but not in JH -/-  or RAG- 
2 -/- Mice.  Because  the  manifestation of disease  pheno- 
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ties (1,  11), we initially established the course of disease of 
IL-2  -/-  mice in our facility by breeding and observing het- 
erozygote  and  homozygote  11_-2 -/-  mice.  Mice  were 
maintained  together  in  one  track  (such  that  their  cages 
would be changed together).  IL-2  -/-  mice generated from 
breedings  of IL-2  +/-  parents  regularly  developed  anemia, 
splenomegaly, and bowel disease, and became moribund or 
died between 18 and 24 wk of age. Some mice (3 out of 10 
IL-2  -/-  mice)  developed  profound  anemia  and  died  be- 
tween 11  and 16 wk of age. These mice had normal colons 
at  necropsy.  IL-2  +/-  mice  were  maintained  in  the  same 
cages  as  their  IL-2  -/-  littermates,  and  all  IL-2  +/-  mice 
lived >40  wk without visible or histopathological  signs of 
illness.  A  total  of 27  mice  (10  IL-2  -/-  and  17  IL-2  § 
mice)  were  studied  before  cross-breeding  of these  mice 
withJH  -/-  and RAG-2  -/-  mice. All IL-2  -/-  mice and no 
IL-2  +/- mice became ill. Thus,  IL-2  -/-  mice regularly de- 
velop bowel disease in our facility. 
During the same period in which we observed the clini- 
cal course oftL-2 -/-  mice in our colony, we observed and 
killed multiple JH -/-  and  RAG-2  -/-  mice maintained  in 
the same track as IL-2  -/-  mice. These mice have been de- 
scribed  before,  but  colonic  histopathology  has  not  been 
performed  (7,  8).  Our  studies  revealed  that JH -/-  mice 
have grossly normal colons. Although immunohistochemi- 
cal stains of colonic sections fromJH  -/-  mice confirm the 
absence of K-positive staining lymphocytes, consistent with 
the inability of  JH -/-  mice to rearrange Ig genes, the histo- 
logical appearance of the colonic epithelium was otherwise 
normal and no epithelial damage, crypt hyperplasia, or signs 
of regeneration were noted (Fig.  1 C). Moreover, no wast- 
ing,  weight  loss,  diarrhea,  premature  death,  or other signs 
of chnical bowel disease were evident inJH -/-  mice main- 
tained for 40 wk.  Thus,  unlike  cytokine- and T  cell--defi- 
cient mice, B  cell-deficient mice do not spontaneously de- 
velop bowel inflammation. 
RAG-2 -/-  mice were also placed in the same track with 
IL-2  -/-  andJH -/-  mice, and they were were observed and 
histologically studied in the same fashion. Among 18 RAG- 
2 -/-  mice  observed for 40  wk,  only  1  mouse  became ill. 
This  mouse  developed  a  wasting  illness;  autopsy  revealed 
pulmonary  lesions  consistent  with  pneumonia  caused  by 
the  protozoan  Pneumocystis  carinii,  an  opportunistic  infec- 
tion  that infrequently  affects RAG-2  -/-  mice.  No  signifi- 
cant bowel inflammation or epithelial damage was seen on 
histopathology.  Furthermore,  necropsy  of  six  additional 
40-wk-old mice failed to reveal evidence of bowel disease. 
Colonic  sections  from  RAG-2  -/-  mice  revealed  no  gross 
evidence  of colonic  inflammation  mediated  by polymor- 
phonuclear  cells,  monocytes,  or  other  nonlymphoid  ira- 
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Figure 2.  Survival  of single- and double-mutant  IL-2  -/-, JH  -/-, and 
RAG-2 -/- mice. Surviving single- and double-mutant mice expressed as 
a percentage of the initial number of animals in each genotype group are 
plotted. All animals were observed until moribund or until 24 wk old, at 
which time necropsies were performed with colonic histopathology and 
hematocrit measurement. Wild type (combined survival of IL-2  +/-, JH  +l- 
and IL-2  +/-, RAG-2 +/- mice (- -E3- -);JH  -/- mice (- -I-q- -); RAG-2 -l- 
mice (  ....  ); IL-2  -/- mice (- -A- -); IL-2-/-,JH  -/- mice (- -(3- -); and 
IL-2  -/-, RAG-2 ~/- (- -0--). 
mune cells.  In addition,  epithehal cells were maintained in 
a  normal  architecture  (Fig.  1  E).  Thus,  RAG-2  -/-  mice, 
like JH -/-  mice,  remained  healthy  during  the  40-wk  ob- 
servation period. Colonic histology of RAG-2 +/- and  JH +~- 
mice, like IL-2  +/- mice, was grossly normal (Fig.  1 A). 
Absence  of  Bowel  Inflammation  in  IL-2-/-,  RAG-2-/- 
Mice.  We  then  bred  IL-2  +/-  mice into  both JH -/-  and 
RAG-2  -/-  backgrounds.  All  parental  strains  were  from a 
mixed  C57B1/6/SV129  background.  All  offspring  were 
genotyped  by PCR.  and/or  Southern  analysis  of genomic 
DNA isolated from tail tips at 3 wk of age. Genotypes were 
confirmed by repeat anaylsis ofgenomic DNA at necropsy. 
Double-heterozygote mice from F1 breedings, i.e.,  IL-2  § 
JH +/-,  and  IL-2  +/-,  RAG-2  +/-  mice,  remained  healthy 
and were interbred  for two  generations.  Fourth,  fifth,  and 
sixth  generation  IL-2  -/-,  JH -/-  and  IL-2  -/-,  RAG-2  -l- 
mice  were  observed  along  with  their  littermate  controls 
until  they  developed  gross  disease,  became  moribund,  or 
until 24 wk of age if they remained healthy. 
IL-2-/-,JH  +/- and  IL-2 -/-,  RAG-2  +/- animals exhib- 
ited a similar wasting disease to IL-2 -/-  mice by 24 wk, in- 
cluding weight  loss,  anemia,  a hunched  stance,  abdominal 
Figure 1.  Histology of single- and double-mutant IL-2-/-,JH -/-, and RAG-2 -/- mice. Colonic sections  from various mice were stained with hema- 
toxylin and eosin. Paired httermates are shown (A and B, C and D, and E and b  3. All sections are  ￿  (.4) IL-2+/-,JH +/- (wild type); (B) IL-2 -/-, 
JH +/- (IL-2  /-); (C) IL-2+/-,JH -/- (JH-/-); (D)  IL-2-/-,JH -/- (IL-2-/-,JH-/-);  (E) IL-2 +/-, RAG-2 -/- (RAG-2-/-);  (F) IL-2  -/-, RAG-2 -/- (tL- 
2-/-, RAG_2-/-). 
1569  Ma et al.  Brief Definitive Report IL.2+I  -  IL-2-1-  IL.2-/-jH-/- 
~  ,:.,  "'" 
m  !":"  "  "  "( 
- 
IgM 
.  "-~.:~.  ....  .-  ~  .... ..  ..;  ..... .-  .  .  ....  '.  ,,.. 
CD8 
.=-  '  .'  .  ."  .  .... 
￿9  :-.-~ ~3 : 12" :;  --"  "  ￿9  2-"  ....  " 
CO3 ~ 
￿9  k"?  "  . 
CO3  :"~  ~  ~"  ' 
.: ~_~T  Figure 3.  FACS  |  analysis of LPLs 
..............  from  IL-2  -/-  and  IL-2  -/-,  JH  -l- 
mice. LPLs from freshly killed nor- 
real (left panels), IL-2 -/- (middle pan- 
els) and IL-2 -/-, JH  -/-  (right panels) 
mouse  colons were  stained  with 
￿9  "::.i:..  : ;  mAbs directed against the following 
￿9  ... :\'"  antigens: PE-B220/FITC-IgM; PE- 
￿9  " ':':-~" "  CD4,  FITC-CD8;  PE-CD69/ 
￿9  2"~ L;~.  FITC-CD3;  and  PE-M290/FITC- 
-~-'  ......  CD3. 
retraction,  loose stools (but rarely rectal bleeding),  and oc- 
casional  rectal  prolapse.  At  autopsy,  distal  segments  (1-5 
cm)  of IL-2 -/-  descending  colons were uniformly thick- 
ened and enlarged. Mesenteric lymph nodes were increased 
3-10-fold in  size as  compared to  control littermates.  Co- 
lonic  histopathology  revealed  gross  infiltration  of colonic 
lamina propria  with lymphocytes, lesser numbers  of poly- 
morphonuclear cells,  crypt abscesses,  and crypt hyperplasia 
and branching, when compared to normal colons (Fig. 1, A 
and B). Loss ofmucin from crypt goblet cells and polymor- 
phonuclear  cell  infiltration  of crypts  was  documented  by 
scanning electron microscopy (data not shown). 
While  IL-2 -/-,  RAG-2 +/-  mice  reproducibly  devel- 
oped  anemia  and  colonic  inflammation  within  24  wk  of 
age,  most  IL-2 -/-,  RAG-2 -/-  double-mutant  littermates 
remained  disease  free  while  sharing  cages  with  IL-2 -/-, 
RAG-2 +/-  littermates  (Fig.  2).  One  IL-2 -/-,  RAG-2 -l- 
mouse  became  ill  during  the  24-wk  observation  period; 
necropsy of this mouse had hepatic and pulmonary lesions 
and  no  colonic inflammation.  To  determine  whether  IL- 
2 -/-,  RAG-2 -/-  mice developed disease in a delayed fash- 
ion, several IL-2 -/-,  RAG-2 -/-  mice were maintained for 
12 too, after which they were killed,  and again no colonic 
lesions were noted.  Thus,  the  elimination  of mature  lym- 
phocytes prevented bowel inflammation and anemia in IL- 
2 -/-  ,  RAG-2 -/-  mice, and demonstrated that either ma- 
ture  B  or T  cells  are  required  for these  manifestations  of 
disease. 
Bowel  Disease  in  IL-2 -/-,  JH -/-  Mice.  To  determine 
whether B  cells  or autoantibodies are necessary for the de- 
velopment of inflammatory bowel disease or anemia in IL- 
2 -/-  mice, we monitored IU2 -/-, JH -/-  mice along with 
IL-2 +/-, JH -/-  and IL-2 -/-, JH +/- littermates.  Except for 
the absence of early (<16 wk old) deaths in IL-2-/-,JH  -l- 
mice  (see below),  IL-2 -/-  mice  developed  a  wasting dis- 
ease  of comparable severity at a similar onset regardless  of 
the  genotype  at  the  JH  locus  (Fig.  2).  Histopathological 
analyses revealed  the  same lymphocyte predominant  infil- 
trates  in  IL-2 -/-,  JH -/-  mice  as  were  seen  in  I1.-2 -/-, 
JH +/-  mice (Fig.  1,  C and D).  Flow cytometric analyses of 
purified  colonic  lamina  propria  lymphocytes  confirmed 
that inflammatory infiltrates from both IL-2-/-,JH  -/-  and 
IL-2 -/-, JH +/-  mice are comprised predominantly of acti- 
vated CD3 +, CD4 +, CD69 +, and M290-  T  cells,  and vir- 
tually no B  cells  (Fig. 3).  Since most routine intraepithelial 
lymphocytes bear the  aM290~  7 integrin,  this  data  suggests 
that intraepithelial  lymphocytes are not a major population 
infiltrating the colons of IL-2 -/-  mice (i0).  Crypt branch- 
ing,  loss of mucin,  and  crypt abscesses in both these  mice 
indicate that bowel inflammation leading to epithelial dana- 
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Figure 4.  Terminal  hematocrit measurements in IL-2 -/~ and IL-2  -/-, 
JH  -]- mice. Blood samples from terminally ill IL- 2 -/- and IL- 2- /-, JH  -/- 
mice, as well as control (]H  +z- andJH  -/-) mice, were taken at necropsy, 
and hematocrits were measured in centrifuged  heparirtized capillary tubes. 
Means (Ix) and SDs were calculated for each group. JH  +/-  mice: Ix = 
48%, SD =  3.0%;JH -/- mice: Ix =  44%, SD =  3.4%; IL-2 -/- mice: Ix 
=  19%, SD = 3.6%; IL-2-/-,JH -/- mice: ~ = 36%, SD = 2.9%. 
age,  rather  than  simple  lymphocyte  infiltration,  has  oc- 
curred  (Fig.  1,  C  and  D).  The  similarity  of disease  onset 
and  severity in  IL-2 -/-,  JH -/-  and  IL-2 -/-,  JH +/-  mice 
indicates  that mature B  cells  and anticolon autoantibodies 
are not necessary for the bowel inflammation that occurs in 
IL-2 -/-  mice. 
Amelioration  of Anemia  in  IL-2 -/-,  JH -/-  Mice.  Some 
IL-2 -/-  mice  developed  severe  anemia  leading  to  death 
within 17 wk of age, before the development of bowel dis- 
ease, while older mice developed severe anemia concomi- 
tantly with  the  development  of severe  bowel disease.  No 
deaths occurred in IL-2 -/-, JH -/-  mice before the age of 
17  wk.  The  mean  hematocrit  from IL-2 -/-,  JH +/-  mice 
(19  --+  3.6%)  was markedly lower than  from terminally ill 
IL-2-/-,JH  -/-  littermates  (36 --- 2.9%)  (P <0.001, Fig. 4). 
HeterozygoteJH +/-  mutant mice possessed a mean  of 48 
-  3.0%,  which  was  not  significantly  different  from  the 
mean fromJH -/-  mutant mice, 44  --- 3.4% (P >0.05,  Fig. 
4). The amelioration of anemia in IL-2 -/-, JH -/-  mice, as 
compared  to  IL-2 -/-,  JH +/-  mice,  indicates  that  B  cells 
contribute significantly to the development of anemia seen 
in IL-2 -/-  mice. This anemia is associated with splenic he- 
mosiderin  deposits  and  an  abundance  of early  erythroid 
forms in peripheral blood smears and splenic sections  (data 
not shown).  The moderate anemia seen in IL-2 -/-, JH -l- 
mice, as compared to normal mice, may result from malnu- 
trition associated with bowel disease. 
Discussion 
Bowel inflammation has been noted in several strains of 
transgenic mice bearing immune deficiencies resulting from 
gene-targeted mutations.  This condition could directly re- 
sult from one  or several types of infections caused by the 
abundant  microbiological  flora  of the  colon,  or  it  could 
represent  an  autoimmune  response  to  intestinal  antigens. 
By establishing that bothJH -/-  and RAG-2 -/-  mice grow 
and live normally without developing bowel inflammation 
in  our colony, we  have  established  that  (a)  immune  defi- 
ciency per  se  does  not  lead  to bowel  inflammation  from 
putative intestinal pathogens in our colony; and (b) neither 
of these immune-deficient conditions leads to spontaneous 
autoimmune  bowel  inflammation.  Furthermore,  the  ab- 
sence of gross bowel disease  in both strains of animals makes 
them appropriate  for directly testing the roles of B  and T 
lymphocytes in murine models of inflammatory bowel dis- 
ease. 
Previous work demonstrated that intestinal luminal con- 
tents influence  the  onset and severity of bowel inflamma- 
tion in IL-2  -/-  mice (3). The absence of  bowel inflarrmaation 
and  general  health  of IL-2 -/-,  RAG-2 -/-  mice  formally 
demonstrates  that  infectious  agents  alone  do  not  cause 
bowel  disease  in  IL-2 -/-  mice.  Rather,  antigen-specific 
immune ceils are required for this process. This process can 
be distinguished from conditions such as the bowel inflam- 
mation  induced  by  oral  administration  of dextran  sulfate 
sodium, since dextran sulfate sodium induces cohtis in both 
SCID  (12)  and  RAG-2 -/-  mice  (Ma,  A.,  unpublished 
data).  It should also be distinguished from the  cecal bowel 
inflammation  seen in  IL-2 ~  chain-deficient  mice,  where 
lymphopenia is associated with the presence of Helicobacter 
helicus  organisms (13). 
The presence of bowel inflammation in several strains of 
transgenic  mice  with  compromised  T  cell  compartments 
suggested  that  the  loss  of a  particular  subset(s)  of T  cells 
might lead to dysregulated B  cell activity and autoimmune 
bowel disease (6).  Our finding that IL-2-/-,JH  -/-  double- 
mutant mice develop disease with comparable severity and 
onset as IL-2 -/-, JH +/-  mice demonstrates  that neither B 
cells nor autoantibodies are necessary for this disease. While 
this does not completely rule out a  role for B  cells in the 
colonic immune response, the similarity of IL-2 -/-, JH -l- 
and IL-2-/-,JH  +/- mice suggests B cells play at most a mi- 
nor role. Formal testing of the role of particular T  cell sub- 
sets in mediating IL-2 -/-  bowel disease by breeding of IL- 
2 -/-  mice  with  TCRoL -/-,  TCR~3 -/-  ,  or  MHC  II  -l- 
mice may be  complicated by the  spontaneous  appearance 
of bowel inflammation in the latter strains of mice (3).  Di- 
rect comparisons of these mouse models of bowel inflam- 
mation await simultaneous studies  of the various strains in 
the same inbred background, in the same facility, and ide- 
ally as interbred llttermates. 
The amelioration of anemic symptoms in IL-2-/-,JH  -/- 
vs IL-2 -/-, JH +/-  mice suggests that B  cells  are important 
for mediating an autoimmune hemolytic anemia in IL-2 -l- 
mice.  The  absence  of MHC  class  I  molecules  on mature 
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ated destruction. The finding that IL-2-/-,JH -/-  mice die 
at approximately the same age as IL-2-/-,JH +/-  mice de- 
spite  retaining  significantly higher  hematocrits  indicates 
that bowel inflammation (vs anemia) is likely to be the ma- 
jor cause  of death  in mice of this  age.  The  separation of 
bowel inflammation from anemia in IL-2 -/-, JH  -/-  mice 
demonstrates  the  use  of B  cell-deficient mice  in  distin- 
guishing the immune mechanisms involved in autoimmune 
processes. JH  -/-  mice have previously been used to dem- 
onstrate the  critical role  of B  cells in mediating nephritis 
and vasculitis in Ipr/lpr  mice  (14).  Bowel inflammation in 
1L-2  -/-  mice is thus pathogenetically distinct from the au- 
toimmune processes seen in Ipr/lpr  mice.  Finally, IL-2 -/-, 
JH  -/  mice are now a useful reagent for studying the spe- 
cific mechanism(s) by which IL-2 -/-  T  cells cause bowel 
inflammation. 
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